SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential inclusion in the Russell 1000 index, driving significant options activity and ongoing conflict between bullish sentiment and short sellers.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending due to a 21% share price drop following the announcement of a $7 billion all-stock acquisition of Synaptics, which has triggered widespread concerns among investors regarding equity dilution. The community is actively debating the strategic long-term value of the deal versus near-term risks, with many traders speculating on an arbitrage-driven recovery or further downside volatility.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor attention driven by anticipation surrounding its NSCLC Phase 3 clinical trial initiation and strategic management moves, including the appointment of a new Chief Commercial Officer. While the community is actively debating the stock's potential for a major buyout and its valuation relative to upcoming regulatory milestones, market participants are also monitoring unusual volume patterns and institutional activity ahead of these key developments.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is capturing significant investor attention as operations ramp up and the company secures key off-take agreements, fueling debates over the stock's potential for a major short squeeze. While community members are divided between concerns over ongoing legal challenges with California regulators and optimism regarding strong federal support and high-margin production, the stock remains a focal point for those betting on the company's ability to navigate these institutional and political hurdles.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased community activity ahead of the upcoming Goliath mainnet launch, which investors are positioning as a critical infrastructure catalyst for the project. While some holders express optimism about long-term institutional adoption and price potential, others remain skeptical, citing concerns over historical price volatility, opaque development communication, and the recurring pattern of quick pumps followed by sharp pullbacks.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is facing increased market volatility following news that a major data center project in Wyoming has been placed on hold, fueling debates about valuation and the near-term timing of energy infrastructure deployments. Despite this, the community remains divided, with some investors viewing the pullback as an accumulation opportunity tied to long-term AI power demand, while others caution that the stock price has outpaced fundamental catalysts.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following a recent strategic collaboration with Jazz Pharmaceuticals and growing investor focus on the company's AI-driven drug discovery platform. The community is actively discussing heavy trading volume, a recent breakout in price action, and anticipation regarding upcoming clinical data readouts.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors focus on its strategic pivot to build a domestic, China-free rare earth supply chain and its upcoming inclusion in the Russell 3000 index. Community discussion is dominated by the companys landmark offtake agreements and potential for government-backed financing to accelerate their midstream processing operations.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is gaining significant momentum as investors digest their expansion into the high-demand edge data center market, with recent contracts and the push for high-density AI infrastructure driving community interest. The stock is currently trending due to its strategic focus on small-scale, modular compute solutions that sidestep the grid and supply-chain bottlenecks facing massive data center projects, fueling speculation about further institutional adoption and strategic partnerships.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened volatility and intense investor speculation fueled by recurring buyout rumors and end-of-quarter index rebalancing. While many in the community debate the company's valuation and leadership performance, the stock remains a focal point for traders tracking clinical trial progress and potential strategic M&A interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dollar General (DG) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

UBER Expands Its Food Delivery Business: Is it a Growth Catalyst?

UBER is expanding Uber Eats with new retailers, pushing beyond food delivery into everyday needs, from skincare and shipping to pet supplies.

Can Target's New Assortment Lift Back-to-School Sales This Year?

Target's back-to-school push blends exclusive collaborations, owned brands, deals and AI-driven shopping tools to win students, parents and teachers.

Can Dollar General Keep Expanding Earnings in Fiscal 2026?

Dollar General's fiscal 2026 earnings growth hinges on margin gains, as shrink reduction, supply-chain productivity and DG Media Network support its outlook.

Can Target's $5 Billion Investment Plan Deliver Strong Returns?

Target's $5B investment push spans stores, remodels, supply chain and tech, with early margin and inventory gains as ROIC slips.

DLTR Trends Show How Value Retail Is Shifting Beyond the Dollar Store

DLTR's multi-price push, delivery access and margin gains show how value retail is evolving beyond the dollar-store model despite traffic pressure.

Is DLTR Stock a Buy as Earnings Rise but Risks Keep Valuation in Check

DLTR's earnings momentum, valuation discount and cash flow support its setup, but traffic softness and cost pressures keep the buy case measured.

Dollar Tree Stock Outlook Hinges on Multi-Price and Margin Momentum

DLTR's outlook rests on multi-price growth and margin gains, as stronger execution must offset softer traffic and cost pressures.

Target Stock Up 31% Year to Date: Should You Buy, Hold or Sell?

Target's 31% year-to-date rally reflects stronger traffic, merchandising, inventory discipline and omnichannel gains, but tougher comparisons loom.

Dollar General's Margin Expansion Story Gains More Traction

Dollar General's margin recovery gains momentum in Q1, as lower shrink, fewer damages and inventory controls lift profits despite higher fuel costs.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

DG’s Upbeat Q1, Improved Guidance Draws Investor Optimism – Here’s What CEO Todd Vasos Said About Navigating Current Macroeconomic Environment

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

DGDollar General Corp.

Fundamentals

Latest DG News